Comparison of the Aperio Hybrid ® and Solitaire FR/X ® stents for anterior circulation stroke thrombectomy across different time periods: A propensity score-matched analysis of recanalization and symptomatic hemorrhage

Abstract

Introduction

Thrombectomy has become the standard treatment for acute ischemic stroke (AIS) caused by large vessel occlusions (LVOs). The Aperio Hybrid (Acandis, Pforzheim, Germany) is a new stent retriever designed to enhance the effectiveness of this treatment. However, this new stent has not yet been compared to other thrombectomy devices in a clinical setting. The aim of this study was to compare the Aperio Hybrid^® with the Solitaire™ FR/X (Medtronic, Minneapolis, USA) during thrombectomy in patients with AIS due to anterior circulation LVO.

Materials and methods

We analyzed data from a multicenter registry of thrombectomy for anterior circulation LVO. Patients with carotid/M1 or proximal M2 occlusions who underwent thrombectomy with either the Aperio Hybrid^® or Solitaire™ FR/X^® were compared using propensity-score matching (PSM). The primary outcome was the recanalization rate, measured by the Treatment in Cerebral Ischemia (TICI) score of 2b-3, while the secondary outcome was the rate of symptomatic intracranial hemorrhage (sICH).

Results

Among 455 patients treated, after PSM, 258 patients (129 per group) were analyzed. The adjusted recanalization rates (TICI 2b-3) for the Aperio Hybrid and Solitaire FR/X were 79.8% and 75.9%, respectively (p = .08), while the adjusted sICH rates were 6.9% and 6.2%, respectively (p = .80).

Conclusions

In this observational study on thrombectomy for AIS, the Aperio Hybrid and Solitaire FR/X demonstrated similar rates of recanalization and symptomatic intracranial hemorrhage. However, due to significant selection bias, these results should be interpreted with caution.

Keywords

Acute ischemic stroke large vessel occlusion mechanical thrombectomy

Get full access to this article

View all access options for this article.

References

Wenger

Nagl

Wagner

, et al. Improvement of stent retriever design and efficacy of mechanical thrombectomy in a flow model. Cardiovasc Intervent Radiol 2013; 36: 192–197.

Saleh

Spence

Nayak

, et al. Safety and efficacy of the Aperio thrombectomy device when compared to the solitaire AB/FR and the revive devices in a pulsatile flow system. Am J Cardiovasc Dis 2012; 2: 301–308.

Roth

Junk

Papanagiotou

, et al. A comparison of 2 stroke devices: the new Aperio clot-removal device and the solitaire AB/FR. AJNR Am J Neuroradiol 2012; 33: 1317–1320.

Powers

Rabinstein

Ackerson

, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American stroke. Stroke 2019; 50: e344–e418.

Al-Mufti

Marden

Burkhardt

, et al. Endovascular therapy for anterior circulation emergent large vessel occlusion stroke in patients with large ischemic cores: a report of the SNIS Standards and Guidelines Committee. J Neurointerv Surg 2024; 16: 870–878.

Mueller-Kronast

Zaidat

Froehler

, et al. Systematic evaluation of patients treated with neurothrombectomy devices for acute ischemic stroke primary results of the STRATIS registry. Stroke 2017; 48: 2760–2768.

Mokin

Abou-Chebl

Castonguay

, et al. Real-world stent retriever thrombectomy for acute ischemic stroke beyond 6 h of onset: analysis of the NASA and TRACK registries. J Neurointerv Surg 2019; 11: 334–337.

Weiss

Kabbasch

Lichtenstein

, et al. A fully radiopaque hybrid stent retriever versus a precursor device: outcome, efficacy, and safety in large vessel stroke. J Neuroimaging 2022; 32: 947–955.

Vogt

Kollikowski

Weidner

, et al. Safety and effectiveness of the new generation Aperio® hybrid stent-retriever device in large vessel occlusion stroke. Clin Neuroradiol 2022; 32: 141–151.